Cost effectiveness of ovarian reserve testing in in vitro fertilization: a Markov decision-analytic model

Individualization of the follicle-stimulating hormone dose according to ovarian reserve is likely to be cost effective in women who are eligible for IVF, but this effectiveness needs to be confirmed in randomized clinical trials.